Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0128USD
−34.00 KUSD
50.67 MUSD
9.63 M
About Integrated BioPharma, Inc.
Sector
Headquarters
Hillside
Employees (FY)
141
Website
Founded
1980
FIGI
BBG000CPR064
Integrated BioPharma, Inc. engages in the manufacturing, distributing, marketing, and sales of vitamins, nutritional supplements, and herbal products. It operates through the following segments: Contract Manufacturing and Other Nutraceutical Businesses. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers. The Other Nutraceutical Businesses segment includes the operation of AgroLabs, Inc., The Vitamin Factory, IHT Health Products, Inc., Manhattan Drug Company (MDC) Warehousing and Distribution, Inc., and Chem International, Inc. The company was founded by E. Gerald Kay in March 1980 and is headquartered in Hillside, NJ.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of INBP is 0.1906 USD — it has decreased by 0.16% in the past 24 hours. Watch Integrated BioPharma, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Integrated BioPharma, Inc. stocks are traded under the ticker INBP.
Integrated BioPharma, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
INBP stock is 10.18% volatile and has beta coefficient of 1.48. Track Integrated BioPharma, Inc. stock price on the chart and check out the list of the most volatile stocks — is Integrated BioPharma, Inc. there?
Yes, you can track Integrated BioPharma, Inc. financials in yearly and quarterly reports right on TradingView.
INBP stock has risen by 5.53% compared to the previous week, the month change is a 1.04% fall, over the last year Integrated BioPharma, Inc. has showed a 47.06% decrease.
INBP net income for the last quarter is −382.00 K USD, while the quarter before that showed −59.00 K USD of net income which accounts for −547.46% change. Track more Integrated BioPharma, Inc. financial stats to get the full picture.
No, INBP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, INBP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Integrated BioPharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
INBP reached its all-time high on May 4, 2004 with the price of 14.0137 USD, and its all-time low was 0.0100 USD and was reached on Nov 14, 2008. View more price dynamics on INBP chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
As of May 6, 2024, the company has 141.00 employees. See our rating of the largest employees — is Integrated BioPharma, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Integrated BioPharma, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Integrated BioPharma, Inc. stock shows the strong sell signal. See more of Integrated BioPharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Integrated BioPharma, Inc. EBITDA is 816.00 K USD, and current EBITDA margin is 2.51%. See more stats in Integrated BioPharma, Inc. financial statements.